financetom
Business
financetom
/
Business
/
Shift4 Payments' H2 Growth Ramp Remains Achievable, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Shift4 Payments' H2 Growth Ramp Remains Achievable, Morgan Stanley Says
Nov 8, 2024 9:10 AM

11:37 AM EST, 11/08/2024 (MT Newswires) -- Shift4 Payments' ( FOUR ) expected growth ramp in the second half is achievable on the back of seasonality benefits, a "healthy" contract pipeline, strong SkyTab performance, and international expansion, Morgan Stanley said in a note Friday.

The company has about $25 billion worth of contracts to be implemented in H2 and its large stadium wins from recent quarters have started to yield more meaningful volumes while organic growth headwinds from softer spend could be offset by the integration of recently completed Revel and Vectron acquisitions, according to the note.

However, the investment firm noted that Shift4 Payments' ( FOUR ) gateway contributions could continue to decline and become a smaller contributor to the company's end-to-end volume growth.

Morgan Stanley reiterated its equal-weight rating on Shift4 Payments ( FOUR ), with a higher price target of $95 from $70.

Shift4 Payments ( FOUR ) shares were up more than 4% in recent trading.

Price: 101.55, Change: +4.01, Percent Change: +4.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Program
Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Program
Aug 29, 2025
Johnson & Johnson ( JNJ ) on Thursday shared topline data from the Phase 2a DAISY proof-of-concept study evaluating the combination of nipocalimab with an anti-tumor necrosis factor alpha (anti-TNFα) therapy in rheumatoid arthritis (RA) patients with refractory disease. Rheumatoid arthritis (RA) is a long-term autoimmune disorder causing inflammation, pain, and swelling in joints, typically the hands and wrists, and...
Crocs Names Patraic Reagan CFO
Crocs Names Patraic Reagan CFO
Aug 29, 2025
07:55 AM EDT, 08/29/2025 (MT Newswires) -- Crocs ( CROX ) said Friday it has appointed Patraic Reagan as executive vice president and chief financial officer, effective Sept. 22. Reagan most recently served as CFO of SharkNinja and will succeed Susan Healy, the company said. Healy will remain with the company as an advisor through Oct. 31, Crocs ( CROX...
Chagee Holdings Q2 Non-GAAP Earnings Decline, Net Revenue Increases
Chagee Holdings Q2 Non-GAAP Earnings Decline, Net Revenue Increases
Aug 29, 2025
07:15 AM EDT, 08/29/2025 (MT Newswires) -- Chagee Holdings ( CHA ) reported Q2 non-GAAP earnings Friday of 3.30 Chinese renminbi ($0.46) per diluted share, down from 3.55 renminbi a year earlier. Analysts' estimates were not readily available for comparison. Total net revenue for the quarter ended June 30 was 3.33 billion renminbi, compared with 3.02 billion renminbi a year...
Galantas Gold Q2 Net Loss Narrows
Galantas Gold Q2 Net Loss Narrows
Aug 29, 2025
07:20 AM EDT, 08/29/2025 (MT Newswires) -- Galantas Gold ( GALKF ) said on Friday that its net loss narrowed in the second quarter. The company booked a net loss of $710,035 for the quarter ended June 30, compared to a year-ago loss of $1.6 million. Revenue remained nil while the company recognized a foreign exchange gain of $656,841 compared...
Copyright 2023-2026 - www.financetom.com All Rights Reserved